Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $11.64-$27.30 |
Market Cap | $4.8B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.20 |
News
See moreYahoo Finance • 15 days ago
Dyne Therapeutics GAAP EPS of -$1.08 misses by $0.33
Yahoo Finance • 16 days ago
Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
Yahoo Finance • 20 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 22 days ago
Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 289 |